Dr. Chonnettia Jones joins MSFHR as Vice President, Research
Dr. Chonnettia Jones, a respected scientist with extensive health research funding experience, joins MSFHR as vice president, research effective April 14, 2020. In her role, Chonnettia will lead our funding programs, ensuring support for our province’s talented health researchers in improving the health of British Columbians and their health system. She will also guide our knowledge translation, partnership and evaluation activities to maximize the impact of MSFHR’s investments in health research.
“We’re really excited to welcome Chonnettia to MSFHR and to British Columbia,” says Dr. Bev Holmes, president and CEO. “She fills a key vacancy at MSFHR and her track record of overseeing funding programs and collaborating to increase the impact of health research funding will be a huge asset to MSFHR. Her background as a developmental neurobiologist gives her a deep understanding of how to support research and researchers.”
Chonnettia joins MSFHR from the Wellcome Trust, a UK-based private foundation dedicated to improving human health through research, innovation, policy and engagement. In her eight years with the organization, she held several progressively more senior roles, culminating as a member of the executive leadership team and the director of insight and analysis, responsible for assessing the performance and impact of Wellcome’s funded research and activities.
“I was drawn to MSFHR because of its mission, improving the health of British Columbians,” says Chonnettia. “MSFHR’s commitment to support research across the continuum, from research to the translation of research to improve health, aligns well with my own interests. I look forward to working with Bev and her team to foster talent development, grow health research capacity, and work with partners to create a more equitable, diverse and inclusive research system.”
Prior to her time at Wellcome, Chonnettia managed a collaborative scientific research program at the Janelia Research Campus of the Howard Hughes Medical Institute. She holds a PhD in biochemistry, cell and developmental biology from Emory University in Atlanta.
Read the full announcement here.